IMS Health Holdings Inc (IMS) : Lateef Investment Management reduced its stake in IMS Health Holdings Inc by 4.33% during the most recent quarter end. The investment management company now holds a total of 7,774,798 shares of IMS Health Holdings Inc which is valued at $191.9 Million after selling 351,633 shares in IMS Health Holdings Inc , the firm said in a disclosure report filed with the SEC on May 13, 2016.IMS Health Holdings Inc makes up approximately 6.05% of Lateef Investment Management’s portfolio.
Other Hedge Funds, Including , Nomura Asset Management Co Ltd boosted its stake in IMS in the latest quarter, The investment management firm added 2,610 additional shares and now holds a total of 18,710 shares of IMS Health Holdings Inc which is valued at $461,763. IMS Health Holdings Inc makes up approx 0.01% of Nomura Asset Management Co Ltd’s portfolio.Gsa Capital Partners Llp reduced its stake in IMS by selling 21,709 shares or 37.2% in the most recent quarter. The Hedge Fund company now holds 36,646 shares of IMS which is valued at $904,423. IMS Health Holdings Inc makes up approx 0.06% of Gsa Capital Partners Llp’s portfolio.D L Carlson Investment Group Inc boosted its stake in IMS in the latest quarter, The investment management firm added 23,125 additional shares and now holds a total of 69,715 shares of IMS Health Holdings Inc which is valued at $1.7 Million. IMS Health Holdings Inc makes up approx 0.64% of D L Carlson Investment Group Inc’s portfolio.Thompson Davis reduced its stake in IMS by selling 6 shares or 1.88% in the most recent quarter. The Hedge Fund company now holds 313 shares of IMS which is valued at $7,753. IMS Health Holdings Inc makes up approx 0.01% of Thompson Davis’s portfolio. Pitcairn Co added IMS to its portfolio by purchasing 8,312 company shares during the most recent quarter which is valued at $221,432. IMS Health Holdings Inc makes up approx 0.03% of Pitcairn Co’s portfolio.
IMS Health Holdings Inc closed down -0.25 points or -0.98% at $25.39 with 21,62,799 shares getting traded on Wednesday. Post opening the session at $25.7, the shares hit an intraday low of $25.37 and an intraday high of $25.77 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
On the company’s financial health, IMS Health Holdings Inc reported $0.42 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.38. The company had revenue of $774.00 million for the quarter, compared to analysts expectations of $749.54 million. The company’s revenue was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.
Many Wall Street Analysts have commented on IMS Health Holdings Inc. IMS Health Holdings Inc was Downgraded by Wells Fargo to ” Market Perform” on May 12, 2016. Company shares were Reiterated by Topeka Capital Markets on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 30 from a previous price target of $29 .Leerink Partners Resumed IMS Health Holdings Inc on Feb 24, 2016 to “Outperform”, Price Target of the shares are set at $31.
IMS Health Holdings Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies including pharmaceutical biotechnology consumer health and medical device manufacturers as well as distributors providers payers government agencies policymakers researchers and the financial community. The Companys principal offerings include national information offerings sub-national information offerings workflow analytics real-world evidence (RWE) solutions technology and applications and clinical solutions.